Verrica Pharmaceuticals Revenue Growth & History (VRCA)

Verrica Pharmaceuticals reported $35.6M in revenue for fiscal 2025, an increase of 370.22% from the previous fiscal year.

View full Verrica Pharmaceuticals company overview

Verrica Pharmaceuticals annual revenue and growth

Verrica Pharmaceuticals annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-12-31$35.6M$28.0M+370.22%
20242024-12-31$7.6M$2.4M+47.66%
20232023-12-31$5.1M−$3.9M−43.27%
20222022-12-31$9.0M−$3.0M−24.73%
20212021-12-31$12.0M
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Verrica Pharmaceuticals filings at SEC.gov ↗